 |
|
|
| |
BMS-986036, a PEGylated Fibroblast Growth Factor 21 Analogue for the Treatment of Non-Alcoholic Steatohepatitis:
A Population Pharmacokinetics and Exposure-Response Analysis
|
| |
| |
Reported by Jules Levin
EASL 2018 April 11-15 Paris France
Giridhar S. Tirucherai,1 Mats O. Magnusson,2 Chayan Acharya,2 Edgar Charles,1 Diane Shevell,1 Rose Christian,1 Yi Luo1
1Bristol-Myers Squibb, Princeton, New Jersey, USA; 2Pharmetheus AB, Uppsala, Sweden
|
| |
|
|
|
|
|
